Literature DB >> 28882703

PEGylation for enhancing nanoparticle diffusion in mucus.

Justin T Huckaby1, Samuel K Lai2.   

Abstract

The viscoelastic mucus secretions coating exposed organs such as the lung airways and the female reproductive tract can trap and quickly eliminate not only foreign pathogens and ultrafine particles but also particle-based drug delivery systems, thus limiting sustained and targeted drug delivery at mucosal surfaces. To improve particle distribution across the mucosa and enhance delivery to the underlying epithelium, many investigators have sought to develop nanoparticles capable of readily traversing mucus. The first synthetic nanoparticles shown capable of rapidly penetrating physiological mucus secretions utilized a dense coating of polyethylene glycol (PEG) covalently grafted onto the surface of preformed polymeric nanoparticles. In the decade since, PEG has become the gold standard in engineering mucus-penetrating drug carriers for sustained and targeted drug delivery to the lungs, gastrointestinal tract, eyes, and female reproductive tract. This review summarizes the history of the development of various PEG-based mucus-penetrating particles, and highlights the key physicochemical properties of PEG coatings and PEGylation strategies to achieve muco-inert PEG coatings on nanoparticle drug carriers for improved drug and gene delivery at mucosal surfaces.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diffusivity; Muco-inert; Mucus; Mucus barrier; Mucus-penetrating; Nanoparticle; PEG

Mesh:

Substances:

Year:  2017        PMID: 28882703     DOI: 10.1016/j.addr.2017.08.010

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  37 in total

Review 1.  Engineering at the nano-bio interface: harnessing the protein corona towards nanoparticle design and function.

Authors:  Rebecca L Pinals; Linda Chio; Francis Ledesma; Markita P Landry
Journal:  Analyst       Date:  2020-07-01       Impact factor: 4.616

Review 2.  Nanoparticle Interactions with the Tumor Microenvironment.

Authors:  Yanyan Huai; Md Nazir Hossen; Stefan Wilhelm; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  Bioconjug Chem       Date:  2019-09-05       Impact factor: 4.774

3.  Tuning the PEG surface density of the PEG-PGA enveloped Octaarginine-peptide Nanocomplexes.

Authors:  Eleni Samaridou; Nikolaos Kalamidas; Irene Santalices; José Crecente-Campo; Maria José Alonso
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

4.  Engineering drug delivery systems to overcome mucosal barriers for immunotherapy and vaccination.

Authors:  Jacob C McCright; Katharina Maisel
Journal:  Tissue Barriers       Date:  2019-11-28

5.  Targeted nanoparticles towards increased L cell stimulation as a strategy to improve oral peptide delivery in incretin-based diabetes treatment.

Authors:  Yining Xu; Herlinde De Keersmaecker; Kevin Braeckmans; Stefaan De Smedt; Patrice D Cani; Véronique Préat; Ana Beloqui
Journal:  Biomaterials       Date:  2020-06-17       Impact factor: 12.479

6.  Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs.

Authors:  Melissa P Lokugamage; Daryll Vanover; Jared Beyersdorf; Marine Z C Hatit; Laura Rotolo; Elisa Schrader Echeverri; Hannah E Peck; Huanzhen Ni; Jeong-Kee Yoon; YongTae Kim; Philip J Santangelo; James E Dahlman
Journal:  Nat Biomed Eng       Date:  2021-10-06       Impact factor: 25.671

7.  The PLGA nanoparticles for sustainable release of CGRP to ameliorate the inflammatory and vascular disorders in the lung of CGRP-deficient rats.

Authors:  Fang Wang; Yu Deng; Jieting Wang; Luying Yu; Fadian Ding; Wei Lian; Qicai Liu; Xinhua Lin
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 8.  Enhancing nanoparticle penetration through airway mucus to improve drug delivery efficacy in the lung.

Authors:  Daiqin Chen; Jinhao Liu; Jerry Wu; Jung Soo Suk
Journal:  Expert Opin Drug Deliv       Date:  2020-12-07       Impact factor: 8.129

Review 9.  Nanoparticle Delivery Systems with Cell-Specific Targeting for Pulmonary Diseases.

Authors:  Zicheng Deng; Gregory T Kalin; Donglu Shi; Vladimir V Kalinichenko
Journal:  Am J Respir Cell Mol Biol       Date:  2021-03       Impact factor: 6.914

Review 10.  Diseases and conditions that impact maternal and fetal health and the potential for nanomedicine therapies.

Authors:  Katherine M Nelson; N'Dea Irvin-Choy; Matthew K Hoffman; Jason P Gleghorn; Emily S Day
Journal:  Adv Drug Deliv Rev       Date:  2020-09-28       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.